Ana Correia

Ana Correia, PhD, is a Senior Scientist Clinical Bioanalytical at Genmab since October 2023. Prior to this role, Ana served as a Scientist in Clinical Immunology at The Janssen Pharmaceutical Companies of Johnson & Johnson from November 2020 to October 2023, specializing in serology assays related to RSV and COVID vaccine programs. Experience includes developing and validating immunologic assays and optimizing cell-based assays for drug screening at Charles River Laboratories. Academic background includes a PhD in Translational Medicine from the University of Amsterdam, a Master's degree in Human Biology from the University of Lisbon, and a Licenciatura in Biochemistry from Universidade do Algarve.